Report copyright - New Accelerating Impactful Medicines to Market · 2020. 2. 12. · CVMED . ertugliflozin T2D, boco hyperlipidemia . CCR2/5, ACC NASH . Delivering Novel & Differentiated Future Potential
Please pass captcha verification before submit form